Charles Schwab Investment Management Inc Meridian Bioscience Inc Transaction History

Charles Schwab Investment Management Inc

$519 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$31.15 - $33.39 $244,434 - $262,011	7,847 Added 2.46%	327,235 $10.9 Million
Q3 2022 Nov 14, 2022	SELL	$30.9 - $33.55 $278,563 - $302,453	-9,015 Reduced 2.75%	319,388 $10.1 Million
Q2 2022 Aug 15, 2022	SELL	$23.75 - $31.69 $411,207 - $548,680	-17,314 Reduced 5.01%	328,403 $9.99 Million
Q1 2022 May 13, 2022	SELL	$19.97 - $26.94 $1.66 Million - $2.24 Million	-83,000 Reduced 19.36%	345,717 $8.98 Million
Q4 2021 Feb 11, 2022	SELL	$17.46 - $21.61 $2.68 Million - $3.31 Million	-153,371 Reduced 26.35%	428,717 $8.75 Million
Q3 2021 Nov 16, 2021	BUY	$17.35 - $22.5 $11,971 - $15,525	690 Added 0.12%	582,088 $11.2 Million
Q2 2021 Aug 16, 2021	BUY	$18.01 - $28.32 $930,792 - $1.46 Million	51,682 Added 9.76%	581,398 $12.9 Million
Q1 2021 May 17, 2021	BUY	$19.76 - $29.89 $718,177 - $1.09 Million	36,345 Added 7.37%	529,716 $13.9 Million
Q4 2020 Feb 16, 2021	BUY	$15.73 - $21.66 $29,871 - $41,132	1,899 Added 0.39%	493,371 $9.22 Million
Q3 2020 Nov 13, 2020	BUY	$13.54 - $26.41 $2.78 Million - $5.42 Million	205,080 Added 71.61%	491,472 $8.35 Million
Q2 2020 Aug 14, 2020	BUY	$7.84 - $23.29 $126,482 - $375,737	16,133 Added 5.97%	286,392 $6.67 Million
Q1 2020 May 15, 2020	BUY	$5.57 - $11.5 $24,675 - $50,945	4,430 Added 1.67%	270,259 $2.27 Million
Q4 2019 Feb 07, 2020	SELL	$7.9 - $10.14 $966,043 - $1.24 Million	-122,284 Reduced 31.51%	265,829 $2.6 Million
Q3 2019 Nov 08, 2019	SELL	$9.17 - $12.01 $350,596 - $459,178	-38,233 Reduced 8.97%	388,113 $3.68 Million
Q2 2019 Aug 09, 2019	SELL	$10.88 - $17.6 $1.41 Million - $2.28 Million	-129,628 Reduced 23.32%	426,346 $5.07 Million
Q1 2019 May 14, 2019	BUY	$15.51 - $17.61 $1.51 Million - $1.71 Million	97,133 Added 21.17%	555,974 $9.79 Million
Q4 2018 Feb 14, 2019	BUY	$14.52 - $19.72 $238,287 - $323,624	16,411 Added 3.71%	458,841 $7.97 Million
Q3 2018 Nov 13, 2018	SELL	$14.85 - $16.35 $93,094 - $102,498	-6,269 Reduced 1.4%	442,430 $6.59 Million
Q2 2018 Aug 08, 2018	SELL	$13.8 - $16.8 $1.64 Million - $2 Million	-119,062 Reduced 20.97%	448,699 $7.14 Million
Q1 2018 May 07, 2018	BUY	$13.8 - $16.2 $1.33 Million - $1.56 Million	96,305 Added 20.43%	567,761 $8.06 Million
Q4 2017 Jan 17, 2018	BUY	$13.55 - $15.8 $704,274 - $821,220	51,976 Added 12.39%	471,456 $6.6 Million
Q3 2017 Nov 13, 2017	BUY	$13.45 - $14.35 $5.64 Million - $6.02 Million	419,480	419,480 $6 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account